These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
765 related items for PubMed ID: 14551492
1. Regional variation in the cost effectiveness of childhood hepatitis A immunization. Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS. Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492 [Abstract] [Full Text] [Related]
3. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL. Pediatrics; 2007 Jan; 119(1):e12-21. PubMed ID: 17200237 [Abstract] [Full Text] [Related]
4. The cost effectiveness of hepatitis immunization for US college students. Jacobs RJ, Saab S, Meyerhoff AS. J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025 [Abstract] [Full Text] [Related]
5. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP. Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247 [Abstract] [Full Text] [Related]
7. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A. Jacobs RJ, Koff RS, Meyerhoff AS. Am J Gastroenterol; 2002 Feb; 97(2):427-34. PubMed ID: 11866283 [Abstract] [Full Text] [Related]
8. Pertussis in adolescents and adults: should we vaccinate? Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA. Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232 [Abstract] [Full Text] [Related]
9. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R. Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737 [Abstract] [Full Text] [Related]
10. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates. Jacobs RJ, Rosenthal P, Meyerhoff AS. Vaccine; 2004 Mar 12; 22(9-10):1241-8. PubMed ID: 15003653 [Abstract] [Full Text] [Related]
11. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Das A. Hepatology; 1999 Feb 12; 29(2):548-52. PubMed ID: 9918934 [Abstract] [Full Text] [Related]
14. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, Zhang X, Stephens DS, Messonnier NE, Active Bacterial Core Surveillance Team. Clin Infect Dis; 2008 Jan 01; 46(1):1-13. PubMed ID: 18171206 [Abstract] [Full Text] [Related]
15. Cost-utility of universal hepatitis A vaccination in Canada. Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD. Vaccine; 2007 Dec 12; 25(51):8536-48. PubMed ID: 17996339 [Abstract] [Full Text] [Related]
17. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Shepard CW, Ortega-Sanchez IR, Scott RD, Rosenstein NE, ABCs Team. Pediatrics; 2005 May 12; 115(5):1220-32. PubMed ID: 15867028 [Abstract] [Full Text] [Related]
19. [Cost-utility analysis on universal childhood hepatitis A vaccination in regions with different anti-HAV prevalence rates of China]. Pan XJ, Feng YM, Zhuang GH. Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug 12; 33(8):862-6. PubMed ID: 22967346 [Abstract] [Full Text] [Related]
20. [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City]. Li X, Xu Z, Hofman A. Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr 12; 19(2):93-6. PubMed ID: 10322718 [Abstract] [Full Text] [Related] Page: [Next] [New Search]